NATCO PHARMA LTD. (NATCOPHARM)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 781.20 1,048.30 930.50 625.30 964.80 1,236.90 1,292.60 407.60 1,157.40 1,192.70 1,264.30 528.80
YOY Revenue Growth % 51.95% 30.11% 165.02% 51.4% 23.5% 17.99% 38.91% -34.82% 19.96% -3.57% -2.19% 29.74%
Other Income 17.50 14.60 24.70 29.50 35.90 39.80 51.40 168.00 62.10 59.60 93.30 55.30
Total Income 798.70 1,062.90 955.20 654.80 1,000.70 1,276.70 1,344.00 575.60 1,219.50 1,252.30 1,357.60 584.10
Total Expenses + 394.60 503.70 473.90 368.50 533.80 479.60 489.30 380.60 698.70 709.40 771.60 458.90
Cost of Materials Consumed 146.30 136.10 166.60 92.20 127.60 151.30 143.20 72.70 169.00 180.60 174.90 135.20
Employee Benefit Expense 97.30 119.20 106.80 103.90 125.00 120.20 132.80 123.60 138.70 143.50 178.60 136.50
Other Expenses 151.00 248.40 200.50 172.40 281.20 208.10 213.30 184.30 235.90 325.80 378.70 160.30
Operating Profit 386.60 544.60 456.60 256.80 431.00 757.30 803.30 27.00 458.70 483.30 492.70 69.90
OPM % 49.5% 52% 49.1% 41.1% 44.7% 61.2% 62.1% 6.6% 39.6% 40.5% 39% 13.2%
Profit Before Tax + 306.40 475.20 424.00 223.60 432.50 758.00 796.90 150.30 520.80 542.90 586.00 125.20
Tax Expense 52.30 69.90 63.80 31.60 83.40 121.70 135.80 25.40 92.70 78.80 85.10 18.30
Tax % 17.1% 14.7% 15% 14.1% 19.3% 16.1% 17% 16.9% 17.8% 14.5% 14.5% 14.6%
Profit After Tax 254.10 405.30 360.20 192.00 349.10 636.30 661.10 124.90 428.10 464.10 500.90 106.90
EPS (Basic) 13.92 22.43 20.11 10.72 19.49 35.53 36.91 6.97 23.90 25.91 27.97 5.97

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 4,094.50 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30
YOY Revenue Growth % 14.73% 51.8% 32.99% 6.91% -7.64% -9.87% -
Other Income 321.30 104.70 85.50 94.60 101.10 123.80 129.80
Total Income 4,415.80 3,673.60 2,436.50 1,862.40 1,754.60 1,914.00 2,116.10
Total Expenses + 2,189.80 1,879.90 1,451.90 1,539.40 1,108.80 1,144.20 1,163.80
Cost of Materials Consumed 536.20 522.50 475.30 519.20 372.90 329.00 333.10
Employee Benefit Expense 515.30 454.90 425.70 410.10 380.00 356.10 340.20
Other Expenses 841.60 902.50 550.90 610.10 355.90 459.10 490.50
Operating Profit 1,904.70 1,689.00 899.10 228.40 544.70 646.00 822.50
OPM % 46.5% 47.3% 38.2% 12.9% 32.9% 36.1% 41.4%
Profit Before Exceptional 2,226.00 1,555.30 770.70 155.90 392.20 583.10 847.40
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 2,226.00 1,555.30 770.70 155.90 392.20 583.10 847.40
Tax Expense 375.60 248.70 133.60 16.80 82.70 108.60 180.30
Tax % 16.9% 16% 17.3% 10.8% 21.1% 18.6% 21.3%
Profit After Tax 1,850.40 1,306.60 637.10 139.10 309.50 474.50 667.10
EPS (Basic) 103.31 72.79 34.90 7.63 16.99 26.08 36.22

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 3,581.90 3,143.60 2,893.20 0.00 0.00 0.00 0.00
Property, Plant & Equipment 2,409.60 2,273.20 2,218.20 0.00 0.00 0.00 0.00
Capital Work in Progress 225.30 133.90 62.80 0.00 0.00 0.00 0.00
Non-Current Investments 74.70 95.90 87.30 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 107.20 13.50 15.60 0.00 0.00 0.00 0.00
Current Assets + 4,688.00 3,410.40 2,494.70 0.00 0.00 0.00 0.00
Inventories 642.10 596.90 616.00 0.00 0.00 0.00 0.00
Trade Receivables 1,178.20 1,076.60 793.10 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 11.20 5.50 6.90 0.00 0.00 0.00 0.00
Current Investments 290.00 163.90 139.90 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 35.80 35.80 36.50 0.00 0.00 0.00 0.00
Other Equity 7,298.10 5,556.50 4,665.50 0.00 0.00 0.00 0.00
Non-Current Liabilities 71.40 76.10 116.90 0.00 0.00 0.00 0.00
Current Liabilities 864.60 885.60 569.00 0.00 0.00 0.00 0.00
Total Liabilities 936.00 961.70 685.90 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 1,662.00 1,196.40 799.80 57.70 0.00 0.00 0.00
Cash from Investing Activities -1,443.90 -960.50 -436.60 -92.50 0.00 0.00 0.00
Cash from Financing Activities -212.40 -237.30 -345.40 35.60 0.00 0.00 0.00
Net Increase/Decrease in Cash 5.70 -1.40 17.80 0.80 0.00 0.00 0.00